Stacey A. Rizza, M.D., F.I.D.S.A., an expert in infectious diseases, is the executive medical director for International Practice and Asia Pacific at Mayo Clinic. Dr. Rizza has experience in laboratory-based research, clinical research, educational initiatives and has maintained a busy clinical practice. She is a professor of medicine and previous chair of the Mayo HIV Clinic, and associate dean of the Mayo Clinic School of Health Sciences. Dr. Rizza has served as the president of the Mayo Clinic staff and as associate director for Diversity and Inclusion in the Mayo Clinic Transplant Center.
Dr. Rizza has earned National Institutes of Health (NIH) grants and received a patent for her work on HIV and HCV mediated apoptosis. She was the chair of the National Comprehensive Cancer Network (NCCN)/African Collaboration for the HIV and Cancer Treatment Guidelines Committee, a member of work groups within the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) and has served on committees and held roles within the Infectious Diseases Society of America, the World Health Organization (WHO), and the Centers for Disease Control and Prevention (CDC).
Dr. Rizza graduated with a degree in biochemistry from Haverford College and received her medical degree from the Mayo Clinic Alix School of Medicine. She did an internal medicine residency and infectious disease fellowship at the Mayo Clinic School of Graduate Medical Education, followed by a postdoctoral fellowship in HIV and HCV immunology at the University of California San Francisco.
Dr. Rizza's experience in international practice and academic initiatives provides a global perspective for healthcare collaborations.
